Gastrointestinal cancers often develop silently but knowing risk factors and warning signs can lead to earlier detection and ...

Many people haven’t heard of Barrett’s Esophagus, but it’s a serious condition that can be a warning sign for a deadly cancer ...

TBC1D30 also has been shown to be highly methylated in colorectal cancer. NELL1 has been shown to be a diagnostic marker of both Barrett's esophagus and colorectal cancer, and hypermethylation of ...

Although esophageal adenocarcinoma is an uncommon cancer, its incidence is rapidly increasing. The aims of the present study were to determine the prevalence of Barrett's metaplasia in outpatients ...

AND YOUR CHANCE OF GETTING CANCER CAN ALSO BE ELIMINATED. BUT MOST PEOPLE WHO HAVE BARRETT’S ESOPHAGUS TODAY, MILLIONS OF AMERICANS RIGHT NOW ARE WALKING AROUND WITH IT HAVE NO IDEA THEY HAVE IT.

2:45-3:30 p.m. The TissueCypher Barrett’s Esophagus test is Castle’s precision medicine test designed to predict future development of high-grade dysplasia (HGD) and/or esophageal cancer in ...

1) Poster Su1466: The Tissue Systems Pathology Test Detected Presence of Missed Neoplasia in a Patient with Non-Dysplastic Barrett’s Esophagus Presenter and Lead Author: Philip Woodworth ...

CDx Diagnostics announced today that new clinical data supporting the utility of the WATS3D test for Barrett's esophagus and dysplasia screening and surveillance has been selected for podium ...

Additionally, an expert physician panel convened by EndoscopyNow will host a product theater on Sunday, May 4, at 2:45 p.m. Pacific Time, titled, “The Time is Now: A Clinical Practice ...

risk stratification in patients with and without a family history of Barrett's esophagus and/or esophageal cancer Presenter: Marcia (Mimi) Canto, M.D., MHS, professor of medicine at The Johns ...

Additionally, an expert physician panel convened by EndoscopyNow will host a product theater on Sunday, May 4, at 2:45 p.m. Pacific Time, titled,“The ...